FDA Clearance Tracker · K250979
Thermogard HQ Temperature Management System, Thermogard XP® Temperature Management System (VitalTemp Universal Pad)
Last checked: Nov 20, 2026Latest source record: Oct 15, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Oct 15, 2025
Substantially Equivalent
Time to decision
198 days
Received Mar 31, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K250979
- Device name
- Thermogard HQ Temperature Management System, Thermogard XP® Temperature Management System (VitalTemp Universal Pad)
- Applicant
- Zoll Circulation, Inc.
- Applicant location
- San Jose, CA
- Received
- Mar 31, 2025
- Decided
- Oct 15, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Hyperthermia Monitor (NZE)
- Device class
- Class II
- Regulation
- 21 CFR 870.5900
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NZE. The earliest in FDA's data is K061023, decided Sep 20, 2006.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K250979
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Zoll Circulation, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K231182 · Decided Nov 3, 2023 · 191 days after receipt
Device type: Hyperthermia Monitor (NZE) · Cardiology
K221700 · Decided Mar 9, 2023 · 269 days after receipt
Device type: Compressor, Cardiac, External (DRM) · Cardiology
K223746 · Decided Jan 13, 2023 · 30 days after receipt
Device type: System, Hypothermia, Intravenous, Cooling (NCX) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.